India Diabetes Market Share, Size, Trends, Outlook, Growth, Segment & Forecast | 2024 - 2032

The India diabetes market was valued at INR 316 billion in 2023, driven by the high prevalence of diabetes across the country. Diabetes is one of the most common and rapidly growing chronic conditions in India, with millions of people living with the disease. The market is expected to grow at a CAGR of 16% from 2024 to 2032, with values projected to rise from INR 366.56 billion in 2024 to INR 1201.74 billion by 2032.

This article delves into the key aspects of the diabetes market in India, including key players, market segments, trends, growth drivers, challenges, and the impact of COVID-19. Additionally, the article sheds light on the market share and size, providing insights into the future of this expanding market.

Get a Free Sample Report with Table of Contents: https://tinyurl.com/2yau7m7v

Overview of Diabetes in India

India, often referred to as the diabetes capital of the world, is home to a significant number of diabetes cases. The high prevalence of diabetes can be attributed to lifestyle changes, unhealthy eating habits, and the increasing number of sedentary jobs. According to recent data, over 70 million people in India suffer from diabetes, with the number expected to rise dramatically in the coming years.

Diabetes is a metabolic disorder that affects the body's ability to produce or effectively use insulin. There are two primary types of diabetes prevalent in India: Type 1 and Type 2 diabetes. Type 2 diabetes is the most common, accounting for over 90% of cases, and is largely associated with lifestyle factors such as obesity, lack of physical activity, and poor diet.

Key Players in the India Diabetes Market

Several pharmaceutical companies, healthcare providers, and diagnostic firms play a crucial role in the diabetes care market in India. These companies are focused on providing treatments, solutions, and diagnostics that improve the quality of life for individuals suffering from diabetes.

Novo Nordisk India

Headquarters: Bangalore, India
Novo Nordisk is a global leader in diabetes care and insulin production. The company has a strong presence in India, offering a range of insulin therapies, including rapid-acting, long-acting, and premixed insulin.
Sanofi India

Headquarters: Mumbai, India
Sanofi is another significant player in the Indian diabetes market, known for its offerings in insulin and diabetes-related healthcare products. Sanofi provides a wide range of medications for both Type 1 and Type 2 diabetes.
Boehringer Ingelheim India

Headquarters: Mumbai, India
Boehringer Ingelheim has emerged as a key player in the oral anti-diabetic market in India, providing innovative oral therapies that help in blood glucose control.
Bayer India

Headquarters: Mumbai, India
Bayer India focuses on providing comprehensive diabetes management solutions, including diagnostics, medications, and lifestyle management tools.
GSK India

Headquarters: Mumbai, India
GlaxoSmithKline offers insulin and oral drugs for diabetes care in India. The company is also involved in diabetes research, focusing on innovative therapies.
Mylan Laboratories (now Viatris)

Headquarters: Mumbai, India
Mylan, a subsidiary of Viatris, manufactures affordable generic medications, including insulin and other diabetes management drugs, making it a key player in the affordable care segment.
These companies are instrumental in shaping the future of diabetes care in India, with a strong focus on expanding access to treatment and innovations in diabetes management.

Read Full Report with Table of Contents: https://tinyurl.com/26sau2tb

Market Segmentation: Diabetes Treatment Market

The diabetes treatment market in India can be segmented based on product type, distribution channel, and end-user.

1. By Product Type

Insulin

Insulin remains the most common form of treatment for Type 1 diabetes and severe cases of Type 2 diabetes. In India, insulin is available in various forms, including injectable and pen devices. The market for insulin is expected to continue growing with increasing demand for rapid-acting and long-acting insulin products.

Oral Anti-Diabetic Drugs

Oral drugs such as metformin, sulfonylureas, and newer class drugs like DPP-4 inhibitors, GLP-1 agonists, and SGLT-2 inhibitors dominate the market. These drugs are used primarily for managing Type 2 diabetes. The segment is expected to experience steady growth, driven by increased awareness and improved healthcare access.

Diabetes Devices

This includes blood glucose monitors, insulin pumps, continuous glucose monitoring systems, and infusion sets. The growing demand for more effective and convenient ways to manage diabetes at home is driving the adoption of these devices.

2. By Distribution Channel

Retail Pharmacies

Retail pharmacies continue to dominate the distribution of diabetes drugs in India. With the increasing penetration of private healthcare networks and the rising demand for over-the-counter medications, retail pharmacies play a significant role in diabetes treatment distribution.
Hospitals and Clinics

Hospitals, clinics, and diabetes care centres are also key players in the distribution channel, providing essential treatments, insulin administration, and continuous care for diabetes patients.

3. By End-User

Hospitals

Hospitals remain the largest end-user segment in the diabetes treatment market. The rising number of diabetes-related hospital visits, including emergency cases, is expected to drive market growth.

Home Care

With the increasing adoption of home care and self-management tools, this segment is growing rapidly. Patients prefer to monitor their blood sugar levels and administer insulin at home, which has increased demand for diabetes devices.

Diabetes Care Centres

Diabetes care centres that offer diagnostic, treatment, and counselling services are emerging as important end-users. These centres provide a holistic approach to managing the disease.

Market Outlook: Growth and Trends

The diabetes market in India is poised for significant growth, driven by several factors, including:

Rising Prevalence of Diabetes

With over 70 million people living with diabetes in India, the market is expected to continue growing due to the increasing prevalence of the disease. Lifestyle changes, unhealthy diets, and stress are contributing factors that are driving the rise in cases.

Technological Advancements in Diabetes Care

The adoption of advanced technologies such as continuous glucose monitoring (CGM) systems, insulin pumps, and mobile health apps is expected to fuel market growth. These technologies allow for better management of blood glucose levels and offer improved quality of life for diabetes patients.

Government Initiatives

The Indian government has undertaken various initiatives to address the growing diabetes burden, including awareness campaigns and improving access to healthcare. These measures are likely to help expand the market and make diabetes care more affordable and accessible.
Focus on Personalized and Preventive Care

As awareness of diabetes increases, there is a growing focus on personalized care, including lifestyle management, diet control, and physical activity. Preventive care solutions that help individuals at risk of developing diabetes are expected to gain traction.

Rising Demand for Insulin and Oral Medications

As the number of diagnosed cases of diabetes grows, so will the demand for insulin, oral anti-diabetic drugs, and other therapies. Oral drugs are expected to see higher growth rates due to their ease of use and cost-effectiveness.

COVID-19 Impact on the India Diabetes Market

The COVID-19 pandemic has had a profound impact on the healthcare sector, including the diabetes market in India. Several aspects of the market have been affected:

Disruptions in Healthcare Services

The pandemic led to disruptions in healthcare services, with many routine diabetes check-ups and treatments delayed. Hospitals and clinics focused on COVID-19 patients, which led to limited access to diabetes care for non-COVID patients.

Shift to Telemedicine

With restrictions on movement and social distancing measures in place, there was a surge in the adoption of telemedicine for managing diabetes. Virtual consultations, digital health tools, and online prescription services have become common.

Supply Chain Interruptions

The supply of diabetes medications and devices was impacted during the initial phases of the pandemic. Shortages of insulin and other medications were reported, which disrupted treatment plans for diabetes patients.
Increased Diabetes Risk

People with diabetes are more vulnerable to severe COVID-19 complications. As a result, there has been a greater focus on managing diabetes and improving patient outcomes to prevent complications.

Despite these challenges, the diabetes market in India is expected to recover and continue growing, especially as the healthcare infrastructure strengthens and digital health tools gain more traction.

Market Trends

Digital Health Solutions

The rise in telemedicine and digital health tools, including mobile applications for diabetes management, is one of the most significant trends. These tools enable patients to monitor their blood sugar levels, track medication adherence, and receive personalised advice from healthcare providers.
Increasing Demand for Insulin Pumps

Insulin pumps are gaining popularity due to their convenience and precision in managing Type 1 diabetes. These devices are expected to be a key growth driver in the diabetes care market.
Shift Toward Preventive Care

With a greater focus on prevention, lifestyle management and preventive therapies are becoming essential parts of the treatment protocol. This shift is expected to drive market growth in the coming years.

FAQs on the India Diabetes Market

1. What is the size of the diabetes market in India?
The market was valued at INR 316 billion in 2023 and is expected to grow at a CAGR of 16%, reaching INR 1201.74 billion by 2032.

2. What are the key factors driving the growth of the diabetes market in India?
The growing prevalence of diabetes, government initiatives, technological advancements in diabetes care, and increased consumer awareness are key growth drivers.

3. Which companies are leading the India diabetes market?
Leading companies include Novo Nordisk, Sanofi India, Boehringer Ingelheim, Bayer, and GSK India.

4. How has COVID-19 impacted the diabetes market in India?
The pandemic led to disruptions in healthcare services, supply chain issues, and a shift to telemedicine. However, the market is expected to recover with stronger digital health adoption.

5. What are the key segments of the diabetes market in India?
The market is segmented by product type (insulin, oral drugs, diabetes devices), distribution channels (retail pharmacies, hospitals, clinics), and end-users (hospitals, home care, diabetes care centres).

Related Trending Reports

Global Myopia Treatment Devices Market : https://tinyurl.com/2aasb2f8
Global Nuclear Medicine Market : https://tinyurl.com/26h58628
Global Craniomaxillofacial Implants Market : https://tinyurl.com/26kz6ofr
Global Acute Myeloid Leukemia Treatment Market : https://tinyurl.com/27zft5wa

Media Contact :

Company Name: Claight Corporation
Contact Person: James william, Corporate Sales Specialist
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.